ArticleBMC psychiatry2026
Patient experiences of benzodiazepine tapering: a qualitative study of treatment in addiction care.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundTapering by gradual dose reduction is a key component of treatment for individuals with addiction to benzodiazepines. Although many patients recover, treatment dropouts and relapses are common. Few studies have explored how benzodiazepine tapering is experienced from the patient perspective.
methodsThis qualitative study involved semi-structured interviews with 19 adults with addiction to benzodiazepines who were undergoing tapering treatment at a publicly funded outpatient addiction clinic. Reflexive thematic analysis was used to analyze the data.
resultsParticipants described benzodiazepine tapering in addiction care as a process marked by substantial variations in experiences and perceived difficulty. Three themes captured central aspects of how tapering was experienced: (1) Navigating motivation and involvement, (2) Replacing benzodiazepines with new coping strategies, and (3) Balancing support throughout treatment.
conclusionsThis study provides an experiential perspective on benzodiazepine tapering in addiction care. The findings illustrate how motivation, coping strategies, and support are closely related to participants' experiences of discontinuation and treatment, highlighting the importance of tapering practices and interpersonal interactions for understanding engagement with treatment.
Indexed as
Identifiers
42850608What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.